Atara Biotherapeutics
ATRA
$0.71
Share price
0.07%
Change (1 day)
-66.17%
Change (1 year)
Categories
EPS for Atara Biotherapeutics (ATRA)
EPS in 2023 (TTM): -$2.78
According to Atara Biotherapeutics's latest financial reports the company's current EPS (TTM) is -$2.78. In 2022 the company made an earnings per share (EPS) of -$2.23 an increase over its 2021 EPS that were of -$3.63.
EPS history for Atara Biotherapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.78 | 24.66% |
| 2022 | -$2.23 | -38.57% |
| 2021 | -$3.63 | -13.78% |
| 2020 | -$4.21 | -26.27% |
| 2019 | -$5.71 | 8.97% |
| 2018 | -$5.24 | 31.33% |
| 2017 | -$3.99 | 45.09% |
| 2016 | -$2.75 | 23.87% |
| 2015 | -$2.22 | 28.85% |
| 2014 | -$1.72 | 168.61% |
| 2013 | -$0.64 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | -$0.31 | -88.85% | 🇺🇸 USA |
 Agenus
AGEN | -$0.85 | -69.42% | 🇺🇸 USA |
 Affimed
AFMD | -$0.79 | -71.58% | 🇩🇪 Germany |